Royalty Pharma invests in a portfolio of drugs, from blockbusters to those still in development.

Protagonist Therapeutics has evolved into a royalty-driven company with two FDA-approved drugs. Read why PTGX stock is a Buy.

A combined numerical and machine-learning study simulates Williamson–Casson hybrid nanofluid flow over a curved stretching ...

TabPFN survival prediction outperformed conventional models on several rare lung cancer prediction tasks, but its advantages ...

This work introduces a framework for constructing Bell inequalities for device-independent certification, allowing exact ...

With the two leading AI powers, the United States and China, forming their own AI blocs, other countries are maneuvering to ...

When Bryan Kohberger sat in an Idaho courtroom in July 2025 and admitted to murdering four University of Idaho students, the ...

The Polymarket promo code AL25BONUS lets you deposit $10 and land a $25 bonus for the NFL Paris Game between the Steelers and ...

Gold fell 29% from its $5,608/oz peak to ~$4,000, with recent volatility testing the $4,000 support level as a potential ...

Global AI development is splitting into US and Chinese spheres. Investors must track how this affects tech supply chains and ...